SCHEMBL6714252

SCHEMBL6714252

OCc1cccc(-c2ccc3c(c2)cc2n3CCNCC2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.54
HTR2C P28335 5/20 0.54
PARP1 P09874 1/20 0.40
TGFB2 P61812 1/20 0.38
ACMSD Q8TDX5 1/20 0.38
CDK8 P49336 1/20 0.38
IKBKB O14920 1/20 0.37
CHUK O15111 1/20 0.37
PRKCI P41743 1/20 0.37
PIK3CA P42336 1/20 0.36
MTOR P42345 1/20 0.36
PIK3CG P48736 1/20 0.36
HRH3 Q9Y5N1 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA7 P36544 1/20 0.35
ALOX5 P09917 1/20 0.35
ABL1 P00519 1/20 0.35
CHRM3 P20309 1/20 0.35
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6712296 0.91 HTR2A (0.54) HTR2AHTR2CPARP1TGFB2ACMSD
SCHEMBL6712401 0.88 HTR2A (0.54) HTR2AHTR2CCDK8IKBKBCHUK
SCHEMBL6711842 0.85 HTR2A (0.51) HTR2AHTR2CCHRM3DHODH
SCHEMBL7606263 0.85 HTR2A (0.51) HTR2AHTR2CPARP1CHRM3
SCHEMBL6714402 0.81 HTR2C (0.58) HTR2AHTR2CCYP2C9
SCHEMBL6715232 0.80 HTR2A (0.47) HTR2AHTR2CPARP1TGFB2CHRNB4
SCHEMBL6713978 0.80 HTR2A (0.71) HTR2AHTR2C
SCHEMBL6713786 0.80 HTR2A (0.56) HTR2AHTR2CIKBKBCHUKHRH3
SCHEMBL6712393 0.79 HTR2A (0.55) HTR2AHTR2CCDK8HRH3KCNH2
SCHEMBL6713843 0.79 HTR2C (0.61) HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040209870-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds ENNIS MICHAEL DALTON (US) 2004-10-21 US disclosed
US-20020002161-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds PHARMACIA & UPJOHN COMPANY 2002-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020002161-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds HTR1D, HTR1A, HTR1E HTR2A 18/4885HTR2C 7/4885PARP1 1281/4885
US-20040209870-A1 Novel 2,3,4,5-tetrahydro-1H-[1,4]diazepino[1,7-a]indole compounds HCRTR2, NR2C2, RCOR3 HTR2A 1403/4885HTR2C 553/4885PARP1 1140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.